Beam Therapeutics Inc.
No enriched coverage for $BEAM in the last 7 days.
No SEC Form 4 filings for $BEAM in the last 30 days.
A Form 144 filing reveals insider sales and restricted stock vesting for ETRADE Financial (NASDAQ: BEAM). John M. Evans sold a total of 50,000 shares across two transactions in late January 2026, totaling over $1.4 million in gross proceeds. Additionally, 66,874 shares tied to restricted stock vesting for services rendered became effective on March 31, 2026.
An insider at Beam Therapeutics Inc. (NASDAQ: BEAM) has scheduled the sale of 25,000 shares after exercising stock options, as indicated by a Rule 144 SEC filing. The filing also notes previous sales by John M. Evans on January 29 and January 30, 2026, each involving 25,000 shares for a total of $734,582.50 and $708,947.50 respectively. This transaction is a routine compliance filing related to the resale of securities following an option exercise.
NULL
